Mri: Clinical Trials

444 trials of Mri, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

164 recruiting, 134 active not recruiting, 56 completed, 27 not yet recruiting. 444 Phase 2, 70 Phase 1, 28 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2444Recruiting 164, Active not recruiting 134, Completed 56, Not yet recruiting 27, Withdrawn 24, Terminated 22, Suspended 13, Enrolling by invitation 2, Unknown 2
Phase 170Recruiting 27, Active not recruiting 15, Completed 13, Terminated 5, Suspended 4, Not yet recruiting 2, Unknown 2, Withdrawn 2
Phase 328Active not recruiting 9, Recruiting 7, Not yet recruiting 5, Completed 3, Suspended 3, Terminated 1

Follow Mri: new trials by email Literature Review of Mri trials Research Report on Mri

Trials (filtered) newest first · largest first

All 444 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial
Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma
Phase 2Not yet recruitingNorthwestern University442027-12-102026-06-10
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center162027-06-012026-02-05
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma
Phase 2Not yet recruitingNorthwestern University562027-05-052026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)742027-04-202026-10-26
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial
Biospecimen Collection, Computed Tomography, Electronic Health Record Review - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma
Phase 2Not yet recruitingNorthwestern University1252027-02-032026-08-06
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group3362027-01-112026-08-14
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple Myeloma
Daratumumab and Recombinant Human Hyaluronidase, Lenalidomide, Bortezomib - Multiple Myeloma (MM)
Phase 2 / Phase 3Not yet recruitingAlliance for Clinical Trials in Oncology9202026-12-232026-10-22
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer
Biospecimen Collection, Computed Tomography, Immunotherapy - Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 2Not yet recruitingNRG Oncology1382026-12-182026-09-23
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Biospecimen Collection, Computed Tomography, Elacestrant - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center502026-12-182026-06-09
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
Biopsy Procedure, Biospecimen Collection, Bone Marrow Biopsy - Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
Phase 2RecruitingCity of Hope Medical Center352026-12-162026-09-29
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Biospecimen Collection, Computed Tomography, Incomplete Freund''s Adjuvant - Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm
Phase 2Not yet recruitingRoswell Park Cancer Institute602026-12-152026-10-20
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 2Not yet recruitingMayo Clinic802026-12-012026-10-05
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Phase 2Not yet recruitingFred Hutchinson Cancer Center502026-12-012026-09-17
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
Nadofaragene Firadenovec, Durvalumab, Gemcitabine - Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 2Not yet recruitingUniversity of Washington332026-12-012026-10-26

Showing 20 of 444. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (38)  ·  Lung Neoplasms (29)  ·  Carcinoma, Non-Small-Cell Lung (26)  ·  Multiple Myeloma (22)  ·  Breast Neoplasms (19)  ·  Lymphoma (19)  ·  Pancreatic Neoplasms (19)  ·  Urinary Bladder Neoplasms (18)  ·  Glioblastoma (17)  ·  Glioma (16)  ·  Neoplasm Metastasis (15)  ·  Carcinoma, Renal Cell (14)  ·  Melanoma (13)  ·  Squamous Cell Carcinoma of Head and Neck (13)  ·  Cholangiocarcinoma (12)

Sponsors

National Cancer Institute (NCI) (172)  ·  Mayo Clinic (45)  ·  University of Washington (15)  ·  City of Hope Medical Center (13)  ·  OHSU Knight Cancer Institute (13)  ·  Children's Oncology Group (12)  ·  Alliance for Clinical Trials in Oncology (11)  ·  Emory University (9)  ·  Fred Hutchinson Cancer Center (9)  ·  Northwestern University (9)  ·  SWOG Cancer Research Network (9)  ·  NRG Oncology (8)  ·  Roswell Park Cancer Institute (8)  ·  ECOG-ACRIN Cancer Research Group (5)  ·  Jonsson Comprehensive Cancer Center (5)

Countries

United States (405)  ·  Canada (41)  ·  Puerto Rico (28)  ·  Australia (18)  ·  France (7)  ·  New Zealand (7)  ·  Guam (4)  ·  Hong Kong (4)  ·  Israel (4)  ·  South Korea (3)  ·  Germany (2)  ·  Ireland (2)  ·  Japan (2)  ·  Norway (2)  ·  Saudi Arabia (2)

Top investigators

Andrei Iagaru (3)  ·  Nilofer S Azad (3)  ·  Patricia M LoRusso (3)  ·  A P Chen (2)  ·  Alain C Mita (2)  ·  Alan L Ho (2)  ·  Andrea B Apolo (2)  ·  Angela Castellanos Rodriguez, MD, MSc (2)  ·  Bhavana Konda (2)  ·  Chad Tang (2)  ·  Devalingam Mahalingam (2)  ·  Funda Meric-Bernstam (2)  ·  Haider S Mahdi (2)  ·  Jacob J. Orme, MD, PhD (2)  ·  Jill Barnes, PhD (2)

Results publications

PMID 31401903, PMID 39571596, PMID 20819978, PMID 21194898, PMID 22571443, PMID 23419134, PMID 23574119, PMID 23810467, PMID 24224624, PMID 25024303, PMID 25218906, PMID 26586415, PMID 26659347, PMID 27185374, PMID 28223062, PMID 28245140, PMID 29223478, PMID 29748435, PMID 29902200, PMID 30125215, PMID 30227893, PMID 31478089, PMID 31969335, PMID 32109194, PMID 32125937, PMID 32463741, PMID 32483359, PMID 32600454, PMID 33048619, PMID 33067126, PMID 33084020, PMID 33303537, PMID 33362722, PMID 33591402, PMID 33602696, PMID 33604999, PMID 33882143, PMID 33927108, PMID 34331515, PMID 34380663, PMID 34406051, PMID 34432874, PMID 34470496, PMID 34486544, PMID 34552007, PMID 34607348, PMID 34716198, PMID 34717797, PMID 34783177, PMID 34907910

NIH funding

U10CA180820 (31), U10CA180868 (26), U10CA180821 (25), U10CA180886 (24), U10CA180888 (23), P30CA060553 (15), P30CA033572 (14), UM1CA186689 (12), UM1CA186691 (10), P30CA138292 (9), UM1CA186709 (9), UM1CA186644 (7), UM1CA186704 (7), UM1CA186686 (5), UM1CA186688 (5)